Related references
Note: Only part of the references are listed.Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials
Rahman Shah et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2017)
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
D. Erlinge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention
Rahman Shah et al.
AMERICAN HEART JOURNAL (2016)
Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis Meta-Analysis of Randomized Controlled Trials
Rahman Shah et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention Insights From the EUROMAX Trial (European Ambulance Acute Coronary Syndrome Angiography)
Peter Clemmensen et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction The BRIGHT Randomized Clinical Trial
Yaling Han et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli et al.
LANCET (2015)
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
M. Valgimigli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction
Stefanie Schulz et al.
EUROPEAN HEART JOURNAL (2014)
Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial
Uwe Zeymer et al.
EUROPEAN HEART JOURNAL (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
Adeel Shahzad et al.
LANCET (2014)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Bivalirudin Started during Emergency Transport for Primary PCI
Philippe Gabriel Steg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
David A. Garcia et al.
CHEST (2012)
Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment-Elevation Myocardial Infarction
Dimitrios Alexopoulos et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Anticoagulant Therapy for Percutaneous Coronary Intervention
Sunil V. Rao et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Bivalirudin: a review of the pharmacology and clinical application
David A. Van De Car et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Bivalirudin during primary PCI in acute myocardial infarction
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction
Antonius A. C. M. Heestermans et al.
THROMBOSIS RESEARCH (2008)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
